CSIMarket
 
Hologic Inc  (NASDAQ: HOLX)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Hologic Inc's Suppliers Performance

HOLX's Supply Chain




 
HOLX Costs vs Sales of Suppliers Growth Hologic Inc's cost of sales deteriorated by -18.11 % year on year, relative to one quarter ago cost of sales fell by -71.29 % in Q1.

More on HOLX Suppliers



Hologic Inc's cost of sales deteriorated by -18.11 % year on year, compare to one quarter ago cost of sales fell by -71.29 % in Q1.

More on HOLX Suppliers




Hologic Inc's Comment on Supply Chain


The company provides diagnostics products, medical imaging systems, and surgical products with a focus on women's health. It distributes its products through direct sales, service personnel, and independent distributors. The Diagnostics segment offers molecular diagnostic assays performed on Panther and Panther Fusion systems, as well as cytology systems including the ThinPrep System, Genius Digital Diagnostics System, and Rapid fFN Test. These assays detect infectious microorganisms, viral loads, bacterial vaginosis, candida vaginitis, respiratory infections, and gastrointestinal pathogens. The Breast Health segment supplies breast imaging, biopsy, surgery, and pathology solutions, including 3D digital mammography systems and related technologies. The company operates a CLIA-certified laboratory for breast cancer testing using the Breast Cancer Index test. The Panther Fusion system enables consolidation of lab-developed tests and in vitro diagnostic assays on a fully automated platform.

Hologic Inc's Comment on Supply Chain


The company provides diagnostics products, medical imaging systems, and surgical products with a focus on women's health. It distributes its products through direct sales, service personnel, and independent distributors. The Diagnostics segment offers molecular diagnostic assays performed on Panther and Panther Fusion systems, as well as cytology systems including the ThinPrep System, Genius Digital Diagnostics System, and Rapid fFN Test. These assays detect infectious microorganisms, viral loads, bacterial vaginosis, candida vaginitis, respiratory infections, and gastrointestinal pathogens. The Breast Health segment supplies breast imaging, biopsy, surgery, and pathology solutions, including 3D digital mammography systems and related technologies. The company operates a CLIA-certified laboratory for breast cancer testing using the Breast Cancer Index test. The Panther Fusion system enables consolidation of lab-developed tests and in vitro diagnostic assays on a fully automated platform.







HOLX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Hologic Inc 17,087.75 3,644.80 543.80 7,070
SUBTOTAL 0.00 0.00 0.00 -


Sources: Hologic Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Hologic Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.